Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2008 Dec;16(6):458–474. doi: 10.1037/a0014103

Table 2.

Ki Values of Test Drugs at 5-HT2 Receptors

Drug Human 5-HT2a Human 5-HT2B Human 5-HT2C
(±)-Fenfluramine 5,216 ± 423 4,134 ± 1,281 3,183 ± 637
(+)-Fenfluramine 11,107 ± 2,303 5,099 ± 1173 6,245 ± 874
(−)-Fenfluramine 5,463 ± 600 5,713 ± 2,285 3,415 ± 922
(±)-Norfenfluramine 2,316 ± 278 52.1 ± 21 557 ± 61
(+)-Norfenfluramine 1,516 ± 150 11.2 ± 7.3 324 ± 12
(−)-Norfenfluramine 3,841 ± 614 47.8 ± 30.6 814 ± 98
Ergotamine 9.0 ± 1.0 3.0 ± 0.4 12 ± 1.5
Methysergide 15.0 ± 4.0 9.1 ± 4.9 1.8 ± 0.2
Methylergonovine 12.6 ± 1.0 0.49 ± 0.16 12.4 ± 1.0
Fluoxetine 299 ± 53 5,030 ± 1,960 50 ± 10
Norfluoxetine 638 ± 108 5,063 ± 1,974 286 ± 60
Trazodone 19.8 ± 2.4 73.6 ± 36 402 ± 44
m-Chlorophenylpiperazine 391 ± 47 3.2 ± 1.0 59 ± 11
5-HT 614 ± 74 4.0 ± 1.9 12.2 ± 1.3
Phentermine >10,000 >10,000 >10,000

Note. Values are mean ± SD for n = 3 experiments. Data taken from Rothman, Baumann et al. (2000).